CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process.
Information about the trials listed below is provided by the CTN.
Small-scale CTN funded studies that are enrolling participants:
CTNPT 001: Fracture case-control study in HIV
CTNPT 005: Measuring cognition in HIV [NEW]
CTNPT 006: The Niaspan® study [NEW]
CTNPT 011: Monitoring penicillin levels for syphilis [NEW]
CTN studies that are enrolling participants:
CTN 260: Raltegravir switch study [NEW]
CTN 257: Impact of HIV on mucosa
CTN 248: Incentives Stop AIDS & HIV in Drug Users [NEW]
CTN 244: STOP HIV & AIDS in IDU
CTN 238: The MAINTAIN study
CTN 222: Canadian co-infection cohort